Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study-Reference-Cited by-同舟云学术

Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study

Published:2007-03 Issue:3 Volume:18 Page:461-467
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bidoli P.,Zilembo N.,Cortinovis D.,Mariani L.,Isa L.,Aitini E.,Cullurà D.,Pari F.,Nova P.,Mancin M.,Formisano B.,Bajetta E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/18/3/461/1347483/mdl415.pdf

Reference31 articles.

1. Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project;Crinò;J Clin Oncol,1999

2. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell-lung cancer;Scagliotti;J Clin Oncol,2002

3. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial;Kelly;J Clin Oncol,2001

4. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial;Rosell;Ann Oncol,2002

5. Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes;Le Chevalier;Lung Cancer,2005

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical Parameters for Particle-Based Pulmonary Delivery of Chemotherapeutics;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2018-06

2. Evaluation of cytotoxic effect of the combination of a pyridinyl carboxamide derivative and oxaliplatin on NCI-H1299 human non-small cell lung carcinoma cells;Biomedicine & Pharmacotherapy;2016-12

3. Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer;Medicine;2015-07

4. Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy;Cancer Chemotherapy and Pharmacology;2015-05-24

5. Phase I Clinical Trial of Ifosfamide, Oxaliplatin, and Etoposide (IOE) in Pediatric Patients With Refractory Solid Tumors;Journal of Pediatric Hematology/Oncology;2015-01